FILE PHOTO: Bill Anderson, CEO of Germany’s drug maker Bayer AG, poses for a portrait session next to the company’s logo at the Bayer headquarters in Leverkusen, Germany, December 10, 2024. REUTERS/Wolfgang Rattay/File Photo
FILE PHOTO: Bill Anderson, CEO of Germany’s drug maker Bayer AG, poses for a portrait session next to the company’s logo at the Bayer headquarters in Leverkusen, Germany, December 10, 2024. REUTERS/Wolfgang Rattay/File Photo